Nasal Antiseptics Market Size

Nasal Antiseptics Market size was over USD 353.92 million in 2024 and is poised to exceed USD 692.59 million by 2037, witnessing over 5.3% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of nasal antiseptics is evaluated at USD 368.93 million. The market is growing as a result of the increasing usage of antiseptic products for pre- and post-operative treatments. Antiseptic solutions are increasingly being used in pre-operative and post-operative procedures to reduce healthcare-acquired infections (HAIs) and surgical site infections (SSIs). Antimicrobial resistance and illnesses linked to healthcare have an incalculable effect on people's lives. In one of the studies conducted in 2022, it was found that the postoperative infection rate following endoscopic sinus surgery was 10%.  

Chronic infections last longer than 90 days, while acute sinus infections resolve within 30 days. Early detection of this illness involves physical examination of the nasal septum, polyps, and mucosa. To treat this infection, you may need an MRI, CT, or ultrasound scan. Corticosteroids, antibiotics, sulfonamides, painkillers, and antihistamines are common medications used to treat sinusitis. The most often-used medications for nasal decontamination include prednisone, mometasone, fluticasone, and triamcinolone.